Alps Advisors Inc Heron Therapeutics, Inc. Transaction History

Alps Advisors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$14.61 - $22.14 $1.69 Million - $2.57 Million	-115,864 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$13.67 - $17.77 $106,461 - $138,392	-7,788 Reduced 6.3%	115,864 $1.72 Million
Q2 2020 Aug 05, 2020	BUY	$10.89 - $21.47 $1.35 Million - $2.65 Million	123,652 New	123,652 $1.82 Million
Q4 2018 Feb 04, 2019	SELL	$22.03 - $32.01 $3.03 Million - $4.4 Million	-137,559 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$30.0 - $40.85 $1.02 Million - $1.38 Million	33,836 Added 32.62%	137,559 $4.35 Million
Q2 2018 Aug 02, 2018	BUY	$26.4 - $42.0 $1.14 Million - $1.82 Million	43,325 Added 71.73%	103,723 $4.03 Million
Q2 2018 Jul 25, 2018	SELL	$26.4 - $42.0 $677,925 - $1.08 Million	-25,679 Reduced 29.83%	60,398 $1.09 Million
Q1 2018 May 01, 2018	BUY	$18.43 - $28.8 $473,263 - $739,555	25,679 Added 42.52%	86,077 $2.38 Million
Q4 2017 Feb 05, 2018	BUY	$14.8 - $18.85 $893,890 - $1.14 Million	60,398	60,398 $1.09 Million

172

114M

32.4K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $268M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.